[...] Other. XLS Corporate and Other | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Operating result (EBIT) –42.9 –52.4 –18.1 EBITDA –39.4 –48.7 –19.1 EBITDA pre one-time items –28.3 –45.3 –37.5 Business free cash flow –31.9 –48.1 –33.6 In the first quarter of 2014, administration expenses recorded under Corporate and Other decreased to € 38 million (Q1 2013: € 43 million). Other operating expenses (net) fell to € –3 million (Q1 2013: € –9 million). This decline was mainly due to a significantly higher foreign currency result, which amounted to € 15 million (Q1 2013: € 4 million). The increase in one-time expenses to [...]

[...] and development costs –378.9 –406.2 Amortization of intangible assets –196.1 –209.6 Operating result (EBIT) 468.3 399.4 Financial result –34.7 –58.7 Profit before income tax 433.6 340.7 Income tax –106.1 –71.7 Profit after tax 327.4 269.0 of which attributable to Merck KGaA shareholders (net income) 325.2 266.0 of which attributable to non-controlling interests 2.2 3.0 Earnings per share (in €) basic 1.50 1.22 diluted 1.50 1.22

XLS Merck Group | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 2,664.8 2,760.5 –3.5 Sales 2,613.9 2,660.4 –1.7 Operating result (EBIT) 468.3 399.4 17.3 Margin (% of sales) 17.9 15.0 EBITDA 770.2 753.8 2.2 Margin (% of sales) 29.5 28.3 EBITDA pre one-time items 807.1 801.1 0.7 Margin (% of sales) 30.9 30.1 Earnings per share (€) 1.50 1.22 23.0 Earnings per share pre one-time items (€) 2.31 2.11 9.5 Business free cash flow 684.1 592.9 15.4 Merck Group | Sales by quarter – Q1 2014 Merck Group | EBITDA pre one-time items by quarter – Q1 2014